Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,295 papers from all fields of science
Search
Sign In
Create Free Account
Synthetic Glioblastoma Tumor-associated Peptides Vaccine Therapy APVAC1
Known as:
APVAC1
A personalized peptide-based cancer vaccine comprised of five to ten peptides associated with glioblastoma (GB), with potential immunomodulating and…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Antigen Sensitization
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Abstract A020: Immunomonitoring for actively personalized peptide vaccines (APVACs) during immunotherapeutic treatment of glioblastoma
Alexander Ulges
,
N. Hilf
,
+20 authors
R. Mendrzyk
Clinical Trials of Cancer Immunotherapies
2019
Corpus ID: 86696622
Cancer immunotherapy to gliomas has so far failed to show encouraging results, as gliomas are rarely mutated and show various…
Expand
2016
2016
Abstract 2654: GAPVAC-101 phase I trial: First data of an innovative actively personalized peptide vaccination trial in patients with newly diagnosed glioblastoma
N. Hilf
,
K. Frenzel
,
+46 authors
H. Singh-Jasuja
2016
Corpus ID: 79435657
The Glioma Actively Personalized Vaccine Consortium (GAPVAC; funded by the European Union Framework 7 Program) aims at treating…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE